Bakheet Elsadek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
Abstract: The present invention relates to a prodrug comprising at least one cytostatic agent, wherein said prodrug is cleavable by prostate-specific antigen (PSA), a process for preparing said prodrug and a pharmaceutical composition containing said prodrug in a pharmaceutically effective amount, for use in the treatment of cancer.
Type:
Grant
Filed:
March 9, 2010
Date of Patent:
February 4, 2014
Assignee:
KTB Tumorforschungsgesellschaft mbH
Inventors:
Felix Kratz, Andre Warnecke, Bakheet Elsadek
Abstract: The present invention relates to a prodrug comprising at least one cytostatic agent, wherein said prodrug is cleavable by prostate-specific antigen (PSA), a process for preparing said prodrug and a pharmaceutical composition containing said prodrug in a pharmaceutically effective amount, for use in the treatment of cancer.
Type:
Application
Filed:
March 9, 2010
Publication date:
April 19, 2012
Applicant:
KTB TUMORFORSCHUNGSGESELLSCHAFT MBH
Inventors:
Felix Kratz, Andre Warnecke, Bakheet Elsadek
© 2024 Justia
